[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Anakinra alone (stages 2b/3);Anakinra and Ruxolitinib (overcome stage 3)", "treatment_type": "Drug;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "Anakinra +/- Ruxolitinib according to clinical stage (gradual strategy): Stage 2b or 3 Anakinra 300 mg IV. Stage 3 : Anakinra 300 mg IV and Ruxolitinib 5 mg x 2", "treatment_id": 83, "treatment_name": "Anakinra", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Anakinra +/- Ruxolitinib according to clinical stage (gradual strategy): Stage 2b or 3 Anakinra 300 mg IV. Stage 3 : Anakinra 300 mg IV and Ruxolitinib 5 mg x 2", "treatment_id": 1409, "treatment_name": "Anakinra+ruxolitinib", "treatment_type": "Interleukin inhibitors+kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]